Clinical Trial Update: Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study comparing LCP-Tacro once daily with Prograf twice daily tacrolimus in adult de novo kidney transplant recipients. Results from th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• LCP-Tacro (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Kidney Failure, Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-05-19